HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update

NEXT STORY
BioXcel Therapeutics Provides an Update on its Ongoing Phase 3 SERENITY Trials
PREV STORY
Orion cancels its Annual General Meeting on Wednesday 25 March 2020 and postpones it to a later date
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sensus Healthcare Expects Record 4Q 2021 Sales and Continued Growth in 1Q 2022; Profiles New Product at the 2022 Winter Clinical Dermatology Conference

author_avatar
NASDAQ Market News

Immunicum AB (publ) Announces Positive Preclinical Data on Ilixadencel in Combination with CTLA-4 Immune Checkpoint Inhibitor

author_avatar
NASDAQ Market News

The global artificial cornea and corneal implant market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026

author_avatar
NASDAQ Market News